Shares Of Adaptive Biotechnologies Tick Up As Compant Announces: 'Adaptive Biotechnologies and Microsoft launch virtual ImmuneRACE study to inform novel COVID-19 diagnostics to address unmet needs in testing'
Benzinga Newsdesk